Global Clinical Trial Disclosure and Data Transparency Conference

Learn about the latest requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.

Early Bird Rates Expire

DAYS

HOURS

MINUTES

SECONDS

Send Email 1.888.257.6457

Back to Agenda

Session 1: Increase Value of Publicly Disclosed Clinical Trial Information

Session Chair(s)

Kelly Coulbourne, MS

Director, Clinical Trial Transparency and Disclosure

Pfizer Inc, United States

Session 1: Increase Value of Publicly Disclosed Clinical Trial Information

Speaker(s)

How Can Value Be Added to Registration and Results Postings?

Representative Invited

Center For the Study of Drug Development, United States

Enabling Individual Participant Data Return (iPDR)

Representative Invited

TransCelerate BioPharma Inc., United States

Update on ClinicalTrials.gov Modernization Effort

Representative Invited

National Institutes of Health (NIH), United States

Have an account?

Global Clinical Trial Disclosure and Data Transparency Conference

Session 1: Increase Value of Publicly Disclosed Clinical Trial Information

Session Chair(s)

Kelly Coulbourne, MS

Speaker(s)

How Can Value Be Added to Registration and Results Postings?

Enabling Individual Participant Data Return (iPDR)

Update on ClinicalTrials.gov Modernization Effort

Be informed and stay engaged.